Gene Editing Markets. By Application, Technology, Place, Industry & Product with Executive and Consultant Guides. 2025 to 2029

Gene Editing is moving from strength to strength. CRISPR and similar tools are finding new uses in every area of biotechnology. It started with Medical applications by changing genes in living human cells. Uncurable diseases have already being cured. More are on the way. A fast growth path is accelerating. New applications are developing in multiple industries. New opportunities are arising with every technological breakthrough. Understand the various opportunities. Find out what is expected in the near term and the long term. Get a handle on realistic growth expectations. Our research makes you the expert in your organization.

All report data is available in Excel format on request.

1. Market Guides

1.1. Strategic Situation Analysis
1.2. Guide for Executives, Marketing, Sales and Business Development Staff
1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

2.1. Methodology
- 2.1.1. Methodology
- 2.1.2. Sources
- 2.1.3. Authors
2.2. What is Gene Editing?
2.3. The CRISPR Example
- 2.3.1. What is CRISPR?
- 2.3.2. The CRISPR Family
2.4. Chromosomes, Genes and Epigenetics
- 2.4.1. Chromosomes
- 2.4.2. Genes
- 2.4.3. Epigenetics
2.5. Market Definition
- 2.5.1. Revenue Market Size
2.6. Perspective: Healthcare Spending
- 2.6.1. Global Healthcare Spending
- 2.6.2. Spending on Healthcare and Pharmaceuticals
- 2.6.3. Spending on Diagnostics
- 2.6.4. Important Role of Insurance for Medical Services

3. Market Structure

3.1. Market Structure Therapeutics
- 3.1.1. Research and Development (R&D) Companies
- 3.1.2. Biotechnology Companies
- 3.1.3. Generic Drug Manufacturers
- 3.1.4. Big Pharmaceuticals
- 3.1.5. Contract Research Organizations (CROs)
- 3.1.6. Contract Manufacturing Organizations (CMOs)
- 3.1.7. Specialty Pharmaceutical Companies
- 3.1.8. Pharmaceutical Distributors
- 3.1.9. Retail Pharmacies
- 3.1.10. Wholesalers
- 3.1.11. Online Pharmacies
- 3.1.12. Health Technology Companies
- 3.1.13. Pharmacy Benefit Managers (PBMs)
- 3.1.14. Clinical Laboratories
- 3.1.15. Medical Device Companies
- 3.1.16. Regulatory Bodies
3.2. Market Structure Diagnostics
- 3.2.1. Academic Research Lab
- 3.2.2. Diagnostic Test Developer
- 3.2.3. Instrumentation Supplier
- 3.2.4. Chemical/Reagent Supplier
- 3.2.5. Pathology Supplier
- 3.2.6. Independent Clinical Laboratory
- 3.2.7. Public National/regional Laboratory
- 3.2.8. Hospital Laboratory
- 3.2.9. Physicians Office Lab (POLS)
- 3.2.10. Audit Body
- 3.2.11. Certification Body

4. Market Trends

4.1. Factors Driving Growth
- 4.1.1. Cell Therapy
- 4.1.2. Gene Therapy
- 4.1.3. The New Agriculture
- 4.1.4. Genetics and Cell Metabolism
4.2. Factors Limiting Growth
- 4.2.1. The Cost Curve
- 4.2.2. Time and Trials
- 4.2.3. The Price Barrier

5. Recent Developments in Gene Editing

5.1. Recent Developments - Importance and How to Use This Section
- 5.1.1. Importance of These Developments
- 5.1.2. How to Use This Section
5.2. CRISPR tool allows for remote-controlled gene-editing
5.3. CRISPR Making Sweeter Tomatoes
5.4. Researchers Create gene-edited prawns
5.5. Gene Editing Corrects Cystic Fibrosis
5.6. CRISPR gene editing to change healthcare?
5.7. CrisprBits Collaborates With MolBio Diagnostics
5.8. Sherlock Bioscience to Launch Free AI-Based Operating System
5.9. Sherlock Biosciences to Acquire Sense Biodetection
5.10. CRISPR Enzyme Discovery Opens New Applications
5.11. Sherlock Biosciences Adds Ambient Amplification to Toolkit
5.12. Rice University Adapts CRISPR Enzyme
5.13. Princeton Group Develops Cas13 Assay for Point-of-Care Use
5.14. Proof Dx Plans Infectious Disease, Oncology Tests for CRISPR-Based POC System
5.15. Sherlock Biosciences Raises $80M
5.16. Broad Institute Considers CRISPR Respiratory Panels to Replace PCR
5.17. Medix Biochemica Acquires MyPols Biotec
5.18. Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets EUA
5.19. Genome Diagnostics Makes Euro-1M Investment in Scope Biosciences
5.20. CRISPR Test Could be used for Asymptomatic Screening
5.21. Mammoth Biosciences, Agilent to Comarket CRISPR-Based SARS-CoV-2 Test
5.22. Pandemic Accelerates Development of CRISPR Diagnostics
5.23. ERS Genomics Licenses CRISPR Patents to Vivlion
5.24. Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test
5.25. ERS Genomics, FASMAC to Commercialize CRISPR-Cas9
5.26. The Nobel Prize in Chemistry 2020 - CRISPR Wins

6. Key Companies

6.1 10x Genomics, Inc.
6.2 4D Molecular Therapeutics
6.3. Abeona Therapeutics
6.4. Acrigen Biosciences
6.5. Adarx Pharmaceuticals
6.6. Adverum Biotechnologies
6.7. Affini-T Therapeutics
6.8. Agilent
6.9. Arbor Biotechnologies
6.10. Arcturus Therapeutics
6.11. Axxam
6.12. Beam Therapeutics
6.13. Beckman Coulter Diagnostics (Danaher)
6.14. Becton, Dickinson and Company
6.15. Binx Health
6.16. bioMerieux Diagnostics
6.17. Bio-Rad Laboratories, Inc.
6.18. Bluebird Bio
6.19. Caribou Biosciences
6.20. Cell Microsystems
6.21. Cellenion (BICO)
6.22. Century Therapeutics
6.23. Chroma Medicine
6.24. Creative Biogene
6.25. Crispr Therapeutics
6.26. Editas Medicine
6.27. ERS Genomics
6.28. FASMAC
6.29. Genscript Biotech
6.30. Illumina
6.31. Inscripta
6.32. Intellia Therapeutics
6.33. J&J Innovative Medicine
6.34. Locus Biosciences
6.35. Mammoth Biosciences
6.36. Metagenomi
6.37. Myllia Biotechnology
6.38. Namocell
6.39. NRGene
6.40. Poseida Therapeutics
6.41. Precision Biosciences
6.42. Prime Medicine
6.43. Proof Diagnostics
6.44. Regeneron Pharmaceuticals
6.45. Revvity
6.46. Roche Diagnostics
6.47. Sherlock Biosciences
6.48. Thermo Fisher Scientific
6.49. Twist Bioscience
6.50. Verve Therapeutics
6.51. Vivlion
6.52. Wave Life Science

7. The Global Market for Gene Editing

7.1. Global Market Overview by Country
- 7.1.1. Table - Global Market by Country
- 7.1.2. Chart - Global Market by Country
7.2. Global Market by Application - Overview
- 7.2.1. Table - Global Market by Application
- 7.2.2. Chart - Global Market by Application - Base/Final Year Comparison
- 7.2.3. Chart - Global Market by Application - Base Year
- 7.2.4. Chart - Global Market by Application - Final Year
- 7.2.5. Chart - Global Market by Application - Share by Year
- 7.2.6. Chart - Global Market by Application - Segment Growth
7.3. Global Market Technology - Overview
- 7.3.1. Table - Global Market by Technology
- 7.3.2. Chart - Global Market by Technology - Base/Final Year Comparison
- 7.3.3. Chart - Global Market by Technology - Base Year
- 7.3.4. Chart - Global Market by Technology - Final Year
- 7.3.5. Chart - Global Market by Technology - Share by Year
- 7.3.6. Chart - Global Market by Technology - Segment Growth
7.4. Global Market Type - Overview
- 7.4.1. Table - Global Market by Type
- 7.4.2. Chart - Global Market by Type - Base/Final Year Comparison
- 7.4.3. Chart - Global Market by Type - Base Year
- 7.4.4. Chart - Global Market by Type - Final Year
- 7.4.5. Chart - Global Market by Type - Share by Year
- 7.4.6. Chart - Global Market by Type - Segment Growth
7.5. Global Market Industry - Overview
- 7.5.1. Table - Global Market by Industry
- 7.5.2. Chart - Global Market by Industry - Base/Final Year Comparison
- 7.5.3. Chart - Global Market by Industry - Base Year
- 7.5.4. Chart - Global Market by Industry - Final Year
- 7.5.5. Chart - Global Market by Industry - Share by Year
- 7.5.6. Chart - Global Market by Industry - Segment Growth
7.6. Global Market Product - Overview
- 7.6.1. Table - Global Market by Product
- 7.6.2. Chart - Global Market by Product - Base/Final Year Comparison
- 7.6.3. Chart - Global Market by Product - Base Year
- 7.6.4. Chart - Global Market by Product - Final Year
- 7.6.5. Chart - Global Market by Product - Share by Year
- 7.6.6. Chart - Global Market by Product - Segment Growth

8. Gene Editing Markets - By Application

8.1. Cell Line
- 8.1.1. Table Cell Line - by Country
- 8.1.2. Chart - Cell Line Growth
8.2. Plant
- 8.2.1. Table Plant - by Country
- 8.2.2. Chart - Plant Growth
8.3. Animal
- 8.3.1. Table Animal - by Country
- 8.3.2. Chart - Animal Growth
8.4. Celll Therapy
- 8.4.1. Table Cell Therapy - by Country
- 8.4.2. Chart - Cell Therapy Growth
8.5. Gene Therapy
- 8.5.1. Table Gene Therapy - by Country
- 8.5.2. Chart - Gene Therapy Growth
8.6. Diagnostics
- 8.6.1. Table Diagnostics - by Country
- 8.6.2. Chart - Diagnostics Growth
8.7. Research
- 8.7.1. Table Research - by Country
- 8.7.2. Chart - Research Growth
8.8. Other Application
- 8.8.1. Table Other Application - by Country
- 8.8.2. Chart - Other Application Growth

9. Global Gene Editing Markets - by Technology

9.1. Crispr
- 9.1.1. Table Crispr - by Country
- 9.1.2. Chart - Crispr Growth
9.2. Talens
- 9.2.1. Table Talens - by Country
- 9.2.2. Chart - Talens Growth
9.3. ZFN
- 9.3.1. Table ZFN - by Country
- 9.3.2. Chart - ZFN Growth
9.4. Meganuclease
- 9.4.1. Table Meganuclease - by Country
- 9.4.2. Chart - Meganuclease Growth
9.5. Other Technology
- 9.5.1. Table Other Technology - by Country
- 9.5.2. Chart - Other Technology Growth

10. Gene Editing Markets - by Place

10.1. In Vivo
- 10.1.1. Table In Vivo - by Country
- 10.1.2. Chart - In Vivo Growth
10.2. Ex Vivo
- 10.2.1. Table Ex Vivo - by Country
- 10.2.2. Chart - Ex Vivo Growth
10.3. In Vitro
- 10.3.1. Table In Vitro - by Country
- 10.3.2. Chart - In Vitro Growth

11. Gene Editing Markets - by Industry

11.1. Pharma
- 11.1.1. Table Pharma - by Country
- 11.1.2. Chart - Pharma Growth
11.2. Clinical
- 11.2.1. Table Clinical - by Country
- 11.2.2. Chart - Clinical Growth
11.3. Academic
- 11.3.1. Table Academic - by Country
- 11.3.2. Chart - Academic Growth
11.4. Contract
- 11.4.1. Table Contract - by Country
- 11.4.2. Chart - Contract Growth
11.5. Other Industry
- 11.5.1. Table Other Industry - by Country
- 11.5.2. Chart - Other Industry Growth

12. Global Gene Editing Markets - by Product

12.1. Instruments
- 12.1.1. Table Instruments - by Country
- 12.1.2. Chart - Instruments Growth
12.2. Cells
- 12.2.1. Table Cells - by Country
- 12.2.2. Chart - Cells Growth
12.3. Reagents
- 12.3.1. Table Reagents - by Country
- 12.3.2. Chart - Reagents Growth
12.4. Other Product
- 12.4.1. Table Other Product - by Country
- 12.4.2. Chart - Other Product Growth

13. Appendices

13.1. United States Medicare System: laboratory Fees Schedule
13.2. The Most Used IVD Assays
13.3. The Highest Grossing Assays
13.4. The Whole Genome Sequence of SARS-CoV-2
13.5. Global Listing of Sequencing Establishments - Location & Contacts

Table of Tables

Table 1: The Base Pairs
Table 2: The Base Pairs
Table 3: Market Players by Type
Table 4: Market Players by Type
Table 5: The Factors Driving Growth
Table 6: Factors Limiting Growth
Table 7: Global Market by Region
Table 8: Global Market by Application
Table 9: Global Market by Technology
Table 10: Global Market by Type
Table 11: Global Market by Industry
Table 12: Global Market by Product
Table 13: Cell Line by Country
Table 14: Plant by Country
Table 15: Animal by Country
Table 16: Cell Therapy by Country
Table 17: Gene Therapy by Country
Table 18: Diagnostics by Country
Table 19: Research by Country
Table 20: Other Application by Country
Table 21: Crispr by Country
Table 22: Talens by Country
Table 23: ZFN by Country
Table 24: Meganuclease by Country
Table 25: Other Technology by Country
Table 26: In Vivo by Country
Table 27: Ex Vivo by Country
Table 28: In Vitro by Country
Table 29: Pharma by Country
Table 30: Clinical by Country
Table 31: Academic by Country
Table 32: Contract by Country
Table 33: Other Industry by Country
Table 34: Instruments by Country
Table 35: Cells by Country
Table 36: Reagents by Country
Table 37: Other Product by Country
Table 38: Clinical Lab Fee Schedule
Table 39: The Most Common Assays
Table 40: Largest Revenue Assays
Table 41: List of Global Sequencing Locations

Table of Figures

Figure 1: DNA Strands and Chromosomes
Figure 2: Karyogram of Human Chromosomes
Figure 3: Size of Various Genomes
Figure 4: Global Per Capita Healthcare Spending
Figure 5: The Road to Therapeutics
Figure 6: The Road to Diagnostics
Figure 7: Cost To Sequence a Human Genome
Figure 8: Base Year Country Market Share Chart
Figure 9: Global Market by Application - Base vs. Final Year
Figure 10: Global Market by Application Base Year
Figure 11: Global Market by Application Final Year
Figure 12: Application Type Share by Year
Figure 13: by Application Segment Growth
Figure 14: by Technology - Base vs. Final Year
Figure 15: by Technology Market Base Year
Figure 16: by Technology Market Final Year
Figure 17: by Technology Share by Year
Figure 18: by Technology Segment Growth
Figure 19: by Type - Base vs. Final Year
Figure 20: by Type Market Base Year
Figure 21: by Type Market Final Year
Figure 22: by Type Share by Year
Figure 23: by Type Segment Growth
Figure 24: by Industry - Base vs. Final Year
Figure 25: by Industry Market Base Year
Figure 26: by Industry Market Final Year
Figure 27: by Industry Share by Year
Figure 28: by Industry Segment Growth
Figure 29: by Product - Base vs. Final Year
Figure 30: by Product Market Base Year
Figure 31: by Product Market Final Year
Figure 32: by Product Share by Year
Figure 33: by Product Segment Growth
Figure 34: Cell Line Growth
Figure 35: Plant Growth
Figure 36: Animal Growth
Figure 37: Cell Therapy Growth
Figure 38: Gene Therapy Growth
Figure 39: Diagnostics Growth
Figure 40: Research Growth
Figure 41: Other Application Growth
Figure 42: Crispr Growth
Figure 43: Talens Growth
Figure 44: ZFN Growth
Figure 45: Meganuclease Growth
Figure 46: Other Organism Growth
Figure 47: In Vivo Growth
Figure 48: Ex Vivo Growth
Figure 49: In Vitro Growth
Figure 50: Pharma Growth
Figure 51: Clinical Growth
Figure 52: Academic Growth
Figure 53: Contract Growth
Figure 54: Other Industry Growth
Figure 55: Instruments Growth
Figure 56: Cells Growth
Figure 57: Reagents Growth
Figure 58: Other Product Growth